Fig. 7
In vivo therapeutic efficacy of phage ZK22. (A) Survival rates of mice treated with different titers of phage ZK22. n = 5. (B) Bacterial load in mice treated with 109 PFU/mL of phage ZK22. n = 4. (C) Relative expression of hepatic inflammatory factors in mice. *P < 0.05